IKCS 2021: Machine Learning Predicts BAP1/PBRM1 From Digital Histology in Clear Cell RCC: TRACERx Renal

(UroToday.com) In the Top Abstracts session of the 2021 International Kidney Cancer Symposium (IKCS): North America meeting, Dr. Spencer presented her work, based on the TRACERx Renal project, to examine the use of machine learning to predict BAP1/PBRM1 using digital histology in patients with clear cell renal cell carcinoma (ccRCC). Beginning, Dr. Spencer emphasized that ccRCC […]

IKCS 2021: The Role of IVC Thrombus with SBRT – Neoadjuvant SBRT  

(UroToday.com) The International Kidney Cancer Symposium 2021 annual hybrid meeting included a role of perioperative therapy in renal cell carcinoma (RCC) session and a presentation by Dr. Raquibul Hannan discussing the role of neoadjuvant stereotactic body radiotherapy in patients with RCC and IVC tumor thrombus. Among patients with newly diagnosed RCC, 4-10% of cases invade the […]

IKCS 2021: First-line (NIVO + IPI) Versus (SUN) in Patients with Long-term survival in the CheckMate 214 Trial

(UroToday.com) In the Top Abstracts session of the 2021 International Kidney Cancer Symposium (IKCS): North America meeting, Dr. Tannir presented work, based on the CheckMate214 trial, examining long-term survival outcomes for patients treated with first-line nivolumab and ipilimumab compared to sunitinib in patients with metastatic renal cell carcinoma (mRCC).

IKCS 2021: Gene Expression Profiling (GEP) of Non-Clear Cell Renal Cell Carcinoma

(UroToday.com) In the Top Abstracts session of the 2021 International Kidney Cancer Symposium (IKCS): North America meeting, Dr. Barata presented their work examining gene expression profiling (GEP) in non-clear cell renal cell carcinoma. He began by highlighting that, while we have seen the emergence of many active treatment options in advanced renal cell carcinoma (RCC), there […]

X